BRD4 and colorectal carcinoma: Consistent with the combination effect of JQ1 and pacritinib in CRC growth, we found that the majority of this gene set showed synergistic downregulation upon the combination treatment, indicating that this gene set is regulated cooperatively by JAK2 and BRD4.